Tomorrow’s Cures. Developed. Delivered. Kincellis Advanced Therapies is a U.S.-based contract development and manufacturing organization supporting advanced therapy developers from early-stage CMC, process and analytical development through clinical supply, pivotal-stage programs, and commercial supply. With facilities in Gainesville, Florida; Research Triangle Park, North Carolina; and The Woodlands, Texas, Kincellis combines broad technical expertise with flexible, scalable GMP infrastructure across autologous and allogeneic therapies, including but not limited to CAR-T, Tregs, CAR-NK, MSCs, dendritic cell vaccines, exosomes, iPSCs & synthetic mRNA.
- Founded
- 2023
- Company size
- 51-200
- Headquarters
- US
- Funding
- Venture-backed
Hiring activity
- Open roles
- 5
- Posted in the last 30 days
- 5
Updated 6h ago
What Kincell Bio says about its culture
What Kincell Bio says it offers, drawn from its own website.
Check if you fitOpens the career fit test.
Kincell Bio’s mission is to help innovators transform promising cell therapy discoveries into commercially available treatments for patients.
Quality first
“Quality first, right scale, better science, reliable supply, and personalized service”Source
Scientific rigor / science-first mindset
“Scientific rigor guides every decision our team makes.”Source
Partnership & collaboration
“Built on Partnership & Collaboration”Source
Right-first-time execution
“We deliver right-first-time execution to ensure compliance, consistency, and readiness for pivotal and commercial success.”Source
They say people do well here who…
- Passionate about innovation, quality, and collaboration
- Disciplined execution and operational reliability
- Inspection-ready mindset with focus on patient safety and rigor
- Collaborative, transparent relationship-builders
Quoted from Kincell Bio's own website. TeaKo does not verify these claims.
Latest openings
5 open roles at Kincell Bio. Members see each one.
